Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

China flag China · Delayed Price · Currency is CNY
23.59
+0.35 (1.51%)
At close: Jul 3, 2026
Market Cap3.79B -23.1%
Revenue (ttm)541.90M +13.2%
Net Income203.65M -4.3%
EPS1.27 -13.6%
Shares Out 160.82M
PE Ratio18.58
Forward PEn/a
Dividend1.07 (4.54%)
Ex-Dividend DateJul 3, 2026
Volume1,556,072
Open23.40
Previous Close23.24
Day's Range23.15 - 23.76
52-Week Range21.31 - 39.47
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHA:603207

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics and traumatology, five senses, and disinfection. Shanghai Xiao Fang Pharmaceutical Co.,Ltd. was founded in 1993 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1993
Employees 529
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603207
Full Company Profile

Financial Performance

In 2025, SHA:603207's revenue was 525.28 million, an increase of 10.68% compared to the previous year's 474.58 million. Earnings were 207.49 million, an increase of 1.08%.

Financial Statements